Lu Wang, Xinghua Qin, Linyan Jin, Haoyu Gong, Chong Gao, Hongtao Wang, Peng Liu
{"title":"Global, regional, and national burden of atrial fibrillation and flutter associated with metabolic risk factors, 1990-2021.","authors":"Lu Wang, Xinghua Qin, Linyan Jin, Haoyu Gong, Chong Gao, Hongtao Wang, Peng Liu","doi":"10.3389/fcvm.2025.1578908","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Atrial fibrillation/flutter (AF/AFL) is increasingly correlated with metabolic risk factors. This study analyzed mortality, disability-adjusted life years (DALYs), annual percentage changes (APCs), and estimated annual percentage changes (EAPCs), stratified by age, sex, Socio-demographic Index (SDI), and region, to evaluate the global burden of AF/AFL linked to metabolic risk factors.</p><p><strong>Methods: </strong>Data on prevalence, incidence, mortality, DALYs, and age-standardized rates (ASRs) for AF/AFL associated with metabolic risk factors were extracted from the Global Burden of Disease (GBD) 2021 study. EAPCs were used to assess temporal trends in ASRs.</p><p><strong>Results: </strong>In 2021, metabolic risk factors were correlated with approximately 117,012 deaths and 2,881,800 DALYs globally due to AF/AFL, reflecting increases of 196.08% and 154.51%, respectively, compared to 1990. The burden varied considerably by sex, SDI, and region. Women, older adults, and high-SDI regions exhibited higher burdens, while men, younger individuals, and low-SDI regions showed more rapid increases.</p><p><strong>Conclusions: </strong>Metabolic risk factors are strongly correlated with the global burden of AF/AFL. Strengthening cost-effective interventions targeting these modifiable risks is essential-particularly in regions facing high or rapidly growing burdens.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1578908"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12450952/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1578908","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Atrial fibrillation/flutter (AF/AFL) is increasingly correlated with metabolic risk factors. This study analyzed mortality, disability-adjusted life years (DALYs), annual percentage changes (APCs), and estimated annual percentage changes (EAPCs), stratified by age, sex, Socio-demographic Index (SDI), and region, to evaluate the global burden of AF/AFL linked to metabolic risk factors.
Methods: Data on prevalence, incidence, mortality, DALYs, and age-standardized rates (ASRs) for AF/AFL associated with metabolic risk factors were extracted from the Global Burden of Disease (GBD) 2021 study. EAPCs were used to assess temporal trends in ASRs.
Results: In 2021, metabolic risk factors were correlated with approximately 117,012 deaths and 2,881,800 DALYs globally due to AF/AFL, reflecting increases of 196.08% and 154.51%, respectively, compared to 1990. The burden varied considerably by sex, SDI, and region. Women, older adults, and high-SDI regions exhibited higher burdens, while men, younger individuals, and low-SDI regions showed more rapid increases.
Conclusions: Metabolic risk factors are strongly correlated with the global burden of AF/AFL. Strengthening cost-effective interventions targeting these modifiable risks is essential-particularly in regions facing high or rapidly growing burdens.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.